ArticleFrontiers in big data2023
A novel approach to fake news classification using LSTM-based deep learning models.
Article in Frontiers in big data, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A federated deep learning framework with distributed hybrid character-level and attention mechanisms for scalable and cost-efficient fake news detection.Scientific reports · 2026Article
- AttBiomarker: unveiling preeclampsia biomarkers and molecular pathways through two-stage gene selection techniques and attention-based CNN with gene regulatory network analysis.Briefings in bioinformatics · 2025Article
- Class-weighted Dempster-Shafer in dual-level fusion for multimodal fake real estate listings detection.PeerJ. Computer science · 2025Article
- Hybrid deep learning models for fake news detection: case study on Arabic and English languages.Frontiers in big data · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid dissemination of information has been accompanied by the proliferation of fake news, posing significant challenges in discerning authentic news from fabricated narratives. This study addresses the urgent need for effective fake news detection mechanisms. The spread of fake news on digital platforms has necessitated the development of sophisticated tools for accurate detection and classification. Deep learning models, particularly Bi-LSTM and attention-based Bi-LSTM architectures, have shown promise in tackling this issue. This research utilized Bi-LSTM and attention-based Bi-LSTM models, integrating an attention mechanism to assess the significance of different parts of the input data. The models were trained on an 80% subset of the data and tested on the remaining 20%, employing comprehensive evaluation metrics including Recall, Precision, F1-Score, Accuracy, and Loss. Comparative analysis with existing models revealed the superior efficacy of the proposed architectures. The attention-based Bi-LSTM model demonstrated remarkable proficiency, outperforming other models in terms of accuracy (97.66%) and other key metrics. The study highlighted the potential of integrating advanced deep learning techniques in fake news detection. The proposed models set new standards in the field, offering effective tools for combating misinformation. Limitations such as data dependency, potential for overfitting, and language and context specificity were acknowledged. The research underscores the importance of leveraging cutting-edge deep learning methodologies, particularly attention mechanisms, in fake news identification. The innovative models presented pave the way for more robust solutions to counter misinformation, thereby preserving the veracity of digital information. Future research should focus on enhancing data diversity, model efficiency, and applicability across various languages and contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.